ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹1.37 Cr | ₹0.89 Cr | ₹0.51 Cr | ₹1.07 Cr | ₹1.36 Cr |
What is the latest Long Term Provisions ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹1.37 Cr |
| Mar2024 | ₹0.89 Cr |
| Mar2023 | ₹0.51 Cr |
| Mar2022 | ₹1.07 Cr |
| Mar2021 | ₹1.36 Cr |
How is Long Term Provisions of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.37 Cr | 54.74 | |
| Mar2024 | ₹0.89 Cr | 75.10 | |
| Mar2023 | ₹0.51 Cr | -52.62 | |
| Mar2022 | ₹1.07 Cr | -21.24 | |
| Mar2021 | ₹1.36 Cr | - | |
Compare Long Term Provisions of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,217.4 Cr | -2.9% | 25.9% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2.9% |
25.9% |
30.2% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses